Sympathetic nerve activity in end-stage renal disease

Circulation

Volumn 106, Issue 15, 2002, Pages 1974-1979

  Hausberg, Martin ^a   Kosch, Markus ^a   Harmelink, Patrick ^a   Barenbrock, Michael ^a   Hohage, Helge ^a   Kisters, Klaus ^a   Dietl, Karl Heinz ^a   Rahn, Karl Heinz ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cyclosporine; Kidney; Kidney failure, chronic; Nervous system, sympathetic; Tacrolimus

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; TACROLIMUS;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEPHRECTOMY; NEUROGRAPHY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; UREMIA;

CALCINEURIN; CYCLOSPORINE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEPHRECTOMY; RENAL DIALYSIS; SYMPATHETIC NERVOUS SYSTEM; TACROLIMUS; UREMIA;

EID: 0037044429     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000034043.16664.96     Document Type: Article

References (24)

1. Rostand SG, Brunzell JD, Cannon RO III, et al. Cardiovascular complications in renal failure. J Am Soc Nephrol. 1991;2:1053-1062.
2. Ligtenberg G, Blankestijn PJ, Oey PL, et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med. 1999;340:1321-1328.
3. Converse RL Jr, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918.
4. Zoccali C, Mallamaci F, Parlongo S, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002;105:1354-1359.
5. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25:878-882.
6. Recordati G, Moss NG, Genovesi S, et al. Renal chemoreceptors. J Auton Nerv Syst. 1981;3:237-251.
7. Lyson T, Ermel LD, Belshaw PJ, et al. Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling. Circ Res. 1993;73:596-602.
8. Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med. 1990;323:693-699.
9. Rundqvist B, Elam M, Eisenhofer G, et al. Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation. J Heart Lung Transplant. 1996;15:516-526.
10. Kaye D, Thompson J, Jennings G, et al. Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. Circulation. 1993;88:1101-1109.
11. Siggard-Anderson J. Venous occlusion plethysmography on the calf. Dan Med Bull. 1970;17:1-68.
12. Hagbarth KE, Vallbo AB. Pulse and respiratory grouping of sympathetic impulses in human muscle nerves. Acta Physiol Scand. 1968;74:96-108.
13. Hausberg M, Mark AL, Hoffman RP, et al. Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertens. 1995;13:1015-1021.
14. Hausberg M, Hoffman RP, Somers VK, et al. Contrasting autonomic and hemodynamic effects of insulin in healthy elderly versus young subjects. Hypertension. 1997;29:700-705.
15. Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int. 1997;51:722-727.
16. Zhang W, Victor RG. Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. Am J Hypertens. 2000;13:999-1004.
17. Zhang W, Li JL, Hosaka M, et al. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci U S A. 2000;97:9765-9770.
18. DiBona GF, Jones SY, Kopp UC. Renal mechanoreceptor dysfunction: an intermediate phenotype in spontaneously hypertensive rats. Hypertension. 1999;33:472-475.
19. Ye S, Gamburd M, Mozayeni P, et al. A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens. 1998;11:723-728.
20. Katholi RE, Whitlow PL, Hageman GR, et al. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens. 1984;2:349-259.
21. Biaggioni I. Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. Hypertension. 1992;20:457-465.
22. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996;7:158-165.
23. Wallin BG, Sundlof G, Stromgren E, et al. Sympathetic outflow to muscles during treatment of hypertension with metoprolol. Hypertension. 1984;6:557-562.
24. Wenzel RR, Allegranza G, Binggeli C, et al. Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics. J Am Coll Cardiol. 1997;29:1607-1614.